Elevance Health
ELV
934 hedge funds and large institutions have $54.2B invested in Elevance Health in 2018 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 296 increasing their positions, 367 reducing their positions, and 71 closing their positions.
62% more call options, than puts
Call options by funds: $385M | Put options by funds: $237M
27% more funds holding in top 10
Funds holding in top 10: 30 → 38 (+8)
25% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 71
9% more capital invested
Capital invested by funds: $49.8B → $54.2B (+$4.44B)
1% more funds holding
Funds holding: 922 → 934 (+12)
0.91% more ownership
Funds ownership: 88.76% → 89.67% (+0.91%)
19% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 367
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$244M |
| 2 |
BlackRock
New York
|
+$198M |
| 3 |
CGI
CI Global Investments
Oakland,
California
|
+$183M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$169M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$162M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
-$233M |
| 2 |
Goldman Sachs
New York
|
-$189M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$188M |
| 4 |
TP
Third Point
New York
|
-$172M |
| 5 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$155M |
ELV Hedge Fund Activity: Q2 2018 in Review
934 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q2 2018, worth a combined $54.2B — up 8.9% from $49.8B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new ELV positions and 71 closed out — a net gain of 18 holders — while 296 added to existing stakes and 367 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $244M. The largest seller was Glenview Capital Management, cutting an estimated $233M.
- 934 institutional investors held Elevance Health (ELV) as of Q2 2018, up from 922 in Q1 2018.
- Funds reported $54.2B of Elevance Health stock for Q2 2018, up 8.9% quarter-over-quarter.
- 89 funds opened new Elevance Health positions in Q2 2018 and 71 closed out, a net change of +18 holders.
- The largest Elevance Health buyer in Q2 2018 was Citadel Advisors, an estimated $244M added.
- The largest Elevance Health seller in Q2 2018 was Glenview Capital Management, an estimated $233M sold.
Based on aggregated 13F filings for Q2 2018.